Senior insider sale
General Counsel at ROCKET PHARMACEUTICALS, INC. — senior position signals high conviction
$270.4K
79.49K shares
What this filing means
WILSON MARTIN plans to sell 79.49K shares of ROCKET PHARMACEUTICALS, INC. valued at approximately $270.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/11/2026ACC: 0001959173-26-006908
Officer· General Counsel
Since Dec 2021
79.49K
Shares to sell
$270.4K
Approx. market value
75.36K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
9/9/2026
75.36KTotal acquired75.36K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/9/2026 | Restricted Stock Vesting Compensation | 75.36K | — |
| Total | 75.36K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
631.00
Market value
$2.1K
8/18/2026
—Completed
Units to sell
3.49K
Market value
$11.8K
8/13/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
75.36K
Market value
$256.5K
9/11/2026
Total
Units
79.49K
Value
$270.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/18/2026 | 631.00 | $2.1K | — | Completed |
8/13/2026 | 3.49K | $11.8K | — | Completed |
| Planned — Approximate Date | ||||
9/11/2026 | 75.36K | $256.5K | NASDAQ | Planned |
| Total | 79.49K | $270.4K | ||